肝脏放射性栓塞中基于Y-90 PET/CT的定量剂量学体模验证
该体模研究评估了Y-90 PET/CT在肝脏放射性栓塞中的定量准确性,并比较了五种剂量计算算法与TLD实测剂量的一致性。结果显示存在活性回收的系统性低估,所有剂量算法表现良好,最差情况吸收剂量一致性在20%以内,Raydose与TLD实测剂量差异在3%以内。作者认为在精确绝对PET校准和足够长采集时间条件下,患者个体化剂量学是可行的,并鼓励常规使用局部沉积算法。
要点
- Y-90 PET可能产生非均匀活性图,即使活性分布均匀,且肿瘤插片和肝脏本底回收活性均系统性低估
- 所有剂量算法表现良好,最差情况吸收剂量一致性在20%以内,Raydose与TLD实测剂量差异在3%以内
- 局部沉积法与MIRD及核卷积法平均吸收剂量高度一致,作者鼓励常规使用局部沉积算法
核心结论
- 患者个体化剂量学在Y-90 PET成像低真符合、高随机分数场景下是可行的,前提是进行准确的绝对PET校准且采集时间足够长。
- 尽管蒙特卡罗计算似乎优于所有剂量估计算法,但作者认为局部沉积算法因实施简单,为常规基于PET/CT的Y-90剂量学提供了有力支持。
研究设计与样本
- 体模研究,使用含肺、肝、脊柱及肝内圆柱形自制病灶的拟人体模评估Y-90 PET定量准确性。
- 比较五种剂量计算方法:Raydose直接蒙特卡罗辐射输运、Philips Stratos核卷积、局部沉积算法、考虑均匀活性分布的MCNP蒙特卡罗技术及MIRD解析法。
- 将计算的吸收剂量与液体环境中LiF:Mg,Cu,P TLD芯片测量结果进行比较。
主要发现
- Y-90 PET可能提供高分辨率图像,但Y-90低分支比及其他图像退化因素可能产生非均匀活性图,即使活性分布均匀。
- 肿瘤插片和肝脏本底的回收活性均出现系统性低估,未通过回收系数进行部分容积校正时尤为明显。
- 所有剂量算法表现良好,最差情况吸收剂量评估间一致性在20%以内。
- 局部沉积法平均吸收剂量与MIRD及核卷积剂量计算法高度一致。
- 蒙特卡罗代码评估的吸收剂量与液体溶液TLD测量高度一致,Raydose提供的吸收剂量值与测量值差异在3%以内,远在所述不确定度范围内。
临床怎么用
- 作者鼓励常规基于PET/CT的Y-90剂量学使用局部沉积算法,因其实施简单。
局限性
- Y-90低分支比及其他图像退化因素可能产生非均匀活性图,即使活性分布均匀。
- 肿瘤插片和肝脏本底回收活性均系统性低估,未应用回收系数进行部分容积校正时尤为明显。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: PET/CT has recently been shown to be a viable alternative to traditional post-infusion imaging methods providing good quality images of 90Y-laden microspheres after selective internal radiation therapy (SIRT). In the present paper, first we assessed the quantitative accuracy of 90Y-PET using an anthropomorphic phantom provided with lungs, liver, spine, and a cylindrical homemade lesion located into the hepatic compartment. Then, we explored the accuracy of different computational approaches on dose calculation, including (I) direct Monte Carlo radiation transport using Raydose, (II) Kernel convolution using Philips Stratos, (III) local deposition algorithm, (IV) Monte Carlo technique (MCNP) considering a uniform activity distribution, and (V) MIRD (Medical Internal Radiation Dose) analytical approach. Finally, calculated absorbed doses were compared with those obtained performing measurements with LiF:Mg,Cu,P TLD chips in a liquid environment. RESULTS: Our results indicate that despite 90Y-PET being likely to provide high-resolution images, the 90Y low branch ratio, along with other image-degrading factors, may produce non-uniform activity maps, even in the presence of uniform activity. A systematic underestimation of the recovered activity, both for the tumor insert and for the liver background, was found. This is particularly true if no partial volume correction is applied through recovery coefficients. All dose algorithms performed well, the worst case scenario providing an agreement between absorbed dose evaluations within 20%. Average absorbed doses determined with the local deposition method are in excellent agreement with those obtained using the MIRD and the kernel-convolution dose calculation approach. Finally, absorbed dose assessed with MC codes are in good agreement with those obtained using TLD in liquid solution, thus confirming the soundness of both calculation approaches. This is especially true for Raydose, which provided an absorbed dose value within 3% of the measured dose, well within the stated uncertainties. CONCLUSIONS: Patient-specific dosimetry is possible even in a scenario with low true coincidences and high random fraction, as in 90Y-PET imaging, granted that accurate absolute PET calibration is performed and acquisition times are sufficiently long. Despite Monte Carlo calculations seeming to outperform all dose estimation algorithms, our data provide a strong argument for encouraging the use of the local deposition algorithm for routine 90Y dosimetry based on PET/CT imaging, due to its simplicity of implementation.
引用
- D'Arienzo M, Pimpinella M, Capogni M, et al. Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization. EJNMMI Res. 2017. PMID: 29185067. doi:10.1186/s13550-017-0341-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。